3.4.24.B14: neprilysin-2
This is an abbreviated version!
For detailed information about neprilysin-2, go to the full flat file.
Word Map on EC 3.4.24.B14
-
3.4.24.B14
-
neprilysins
-
alzheimer
-
endopeptidases
-
amyloid
-
thiorphan
-
phosphoramidon
-
metalloproteases
-
neuropeptides
-
3.4.24.11
-
zinc-dependent
-
medicine
- 3.4.24.B14
- neprilysins
- alzheimer
- endopeptidases
-
amyloid
- thiorphan
- phosphoramidon
- metalloproteases
- neuropeptides
-
3.4.24.11
-
zinc-dependent
- medicine
Reaction
proteolytic degradation of proteins =
Synonyms
M13.008, membrane metallo-endopeptidase-like protein, membrane-bound metalloendopeptidase-like enzyme 1, membrane-bound metalloendopeptidase-like enzyme 2, MMEL, MMEL1, MMEL2, More, NEP-like endopeptidase, NEP2, NEP2(s), NEPII, NEPLP, neprilysin 2, neprilysin-2, neprilysin-like protein, NL-1, Nl1, NL1 protein, SEP, soluble-secreted endopeptidase
ECTree
Advanced search results
Expression
Expression on EC 3.4.24.B14 - neprilysin-2
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
NEP2 expression is measured in non-impaired, mild cognitive impaired, and clinical Alzheimer's disease human brain tissue from two Alzheimer's disease -susceptible and two resistant regions. NEP2 and NEP mRNA expression is altered in mild cognitive impaired subjects relative to non-impaired subjects in Alzheimer's disease -susceptible regions. NEP2 enzymatic activity is lowered in association with mild cognitive impaired and Alzheimer's disease and is positively associated with cognitive function, independent of diagnostic category
-
the altered enzyme expression has a sexually dimorphic change, with mild-cognitive impaired males having significantly elevated NEP2 mRNA levels compared to non-impaired males in the mid-temporal and mid-frontal gyri